Brain, behavior, and immunity

A new Bacillus aerolatus strain helps reduce brain damage from dextromethorphan by changing gut bacteria and brain signaling in the memory area

Updated

Abstract

Dextromethorphan (DM) exposure in mice led to significant changes in gut microbiota and neurobehavioral impairments.

  • DM exposure resulted in altered gut microbial composition, with increased Akkermansia and Desulfovibrionaceae and decreased Muribaculaceae.
  • Reduced fecal butyrate levels were observed alongside impaired intestinal barrier function and increased inflammatory markers.
  • In the brain, DM exposure increased pro-inflammatory cytokines and activated glial cells, suppressing the Apelin-PI3K/Akt/mTOR signaling pathway.
  • These changes were linked to increased anxiety-like behaviors and impaired spatial memory in mice.
  • Prophylactic administration of the probiotic Bacillus aerolatus CX253 helped preserve gut microbiota diversity and elevated beneficial microbial taxa.
  • CX253 treatment restored butyrate levels, improved intestinal barrier function, and mitigated both peripheral and central inflammation, enhancing neurobehavioral performance.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free